Biolux Research closes $14 mln Series A round led by Venrock
Biolux Research, a Vancouver-based developer of light-accelerated orthodontic products, has raised $14 million in a Series A financing. The round was led by Venrock, a U.S. technology and healthcare venture capital firm. It was joined by Correlation Ventures and other investors. Founded in 2007, Biolux is the maker of OrthoPulse, a non-invasive device that uses low levels of light energy to accelerate orthodontic treatments. The product is currently being sold in the United States, Europe and Asia. The company also announced the appointment of David Thrower, a medical device industry executive, as its new CEO.
30 April 2019•3 mins read
